Covington Capital Management trimmed its holdings in shares of Cerner Co. (NASDAQ:CERN) by 1.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 119,259 shares of the company’s stock after selling 1,845 shares during the quarter. Covington Capital Management’s holdings in Cerner were worth $8,037,000 at the end of the most recent reporting period.
Several other large investors have also added to or reduced their stakes in the company. Icon Wealth Partners LLC bought a new stake in shares of Cerner in the fourth quarter valued at about $107,000. Fuller & Thaler Asset Management Inc. bought a new stake in shares of Cerner in the third quarter valued at about $121,000. Cerebellum GP LLC bought a new stake in shares of Cerner in the fourth quarter valued at about $127,000. Steward Partners Investment Advisory LLC bought a new stake in shares of Cerner in the third quarter valued at about $128,000. Finally, Delpha Capital Management LLC bought a new stake in shares of Cerner in the fourth quarter valued at about $144,000. Institutional investors and hedge funds own 78.56% of the company’s stock.
In other news, Director William D. Zollars sold 4,100 shares of the business’s stock in a transaction dated Thursday, February 8th. The stock was sold at an average price of $62.16, for a total transaction of $254,856.00. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Vice Chairman Clifford W. Illig sold 307,700 shares of the business’s stock in a transaction dated Thursday, March 8th. The stock was sold at an average price of $64.52, for a total value of $19,852,804.00. Following the sale, the insider now owns 1,229,719 shares in the company, valued at approximately $79,341,469.88. The disclosure for this sale can be found here. Insiders sold 541,800 shares of company stock worth $34,353,860 in the last quarter. 13.11% of the stock is owned by insiders.
Cerner Co. (CERN) traded down $0.39 on Wednesday, reaching $62.66. The company’s stock had a trading volume of 278,915 shares, compared to its average volume of 2,413,431. Cerner Co. has a 52 week low of $55.14 and a 52 week high of $73.86. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.01 and a quick ratio of 2.99. The stock has a market capitalization of $21,499.09, a price-to-earnings ratio of 24.53, a PEG ratio of 1.88 and a beta of 0.93.
Cerner (NASDAQ:CERN) last posted its earnings results on Tuesday, February 6th. The company reported $0.58 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.61 by ($0.03). Cerner had a net margin of 16.86% and a return on equity of 16.82%. The company had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.33 billion. During the same quarter last year, the firm earned $0.61 EPS. Cerner’s revenue for the quarter was up 4.5% on a year-over-year basis. research analysts predict that Cerner Co. will post 2.42 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this news story on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2018/03/14/cerner-co-cern-shares-sold-by-covington-capital-management.html.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.